[HTML][HTML] Tocilizumab and COVID-19: timing of administration and efficacy
E Abidi, WS El Nekidy, E Alefishat, N Rahman… - Frontiers in …, 2022 - frontiersin.org
Elevated concentrations of interleukin-6 have been demonstrated to be an important key
factor in COVID-19 host immune impairment. It represents an important prognostic factor of …
factor in COVID-19 host immune impairment. It represents an important prognostic factor of …
[HTML][HTML] Cardiopulmonary exercise pattern in patients with persistent dyspnoea after recovery from COVID-19
A Mohr, L Dannerbeck, TJ Lange, M Pfeifer… - Multidisciplinary …, 2021 - ncbi.nlm.nih.gov
Cause and mechanisms of persistent dyspnoea after recovery from COVID-19 are not well
described. The objective is to describe causal factors for persistent dyspnoea in patients …
described. The objective is to describe causal factors for persistent dyspnoea in patients …
Multiscale models of Covid-19 with mutations and variants
N Bellomo, D Burini, N Outada - Networks and Heterogeneous …, 2022 - aimsciences.org
This paper focuses on the multiscale modeling of the COVID-19 pandemic and presents
further developments of the model [7] with the aim of showing how relaxations of the …
further developments of the model [7] with the aim of showing how relaxations of the …
[HTML][HTML] Is loss of smell an early predictor of COVID-19 severity: a systematic review and meta-analysis
Anecdotal evidence suggests that the severity of coronavirus disease of 2019 (COVID-19),
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is likely to be …
caused by severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2), is likely to be …
Human cathelicidin inhibits SARS-CoV-2 infection: killing two birds with one stone
C Wang, S Wang, D Li, P Chen, S Han… - ACS infectious …, 2021 - ACS Publications
SARS-CoV-2 infection begins with the association of its spike 1 (S1) protein with host
angiotensin-converting enzyme-2 (ACE2). Targeting the interaction between S1 and ACE2 …
angiotensin-converting enzyme-2 (ACE2). Targeting the interaction between S1 and ACE2 …
Insight into the pediatric and adult dichotomy of COVID‐19: age‐related differences in the immune response to SARS‐CoV‐2 infection
A Fialkowski, Y Gernez, P Arya… - Pediatric …, 2020 - Wiley Online Library
The difference in morbidity and mortality between adult and pediatric coronavirus disease
2019 infections is dramatic. Understanding pediatric‐specific acute and delayed immune …
2019 infections is dramatic. Understanding pediatric‐specific acute and delayed immune …
[HTML][HTML] Mild Cytokine Elevation, Moderate CD4+ T Cell Response and Abundant Antibody Production in Children with COVID-19
R Jia, X Wang, P Liu, X Liang, Y Ge, H Tian, H Chang… - Virologica Sinica, 2020 - Springer
Abstract Children with Coronavirus Disease 2019 (COVID-19) were reported to show milder
symptoms and better prognosis than their adult counterparts, but the difference of immune …
symptoms and better prognosis than their adult counterparts, but the difference of immune …
[HTML][HTML] COVID-19 and pediatric asthma: clinical and management challenges
JL Boechat, GF Wandalsen, FC Kuschnir… - International journal of …, 2021 - mdpi.com
Asthma is the most frequent chronic condition in childhood and a current concern exists
about asthma in the pediatric population and its risk for severe SARS-CoV-2 infection …
about asthma in the pediatric population and its risk for severe SARS-CoV-2 infection …
[HTML][HTML] Changes in dietary patterns and clinical health outcomes in different countries during the SARS-CoV-2 pandemic
Coronavirus disease 2019 (COVID-19), caused by severe acute respiratory syndrome
coronavirus 2 (SARS-CoV-2), has led to an excess in community mortality across the globe …
coronavirus 2 (SARS-CoV-2), has led to an excess in community mortality across the globe …
[HTML][HTML] Complement and COVID-19: Three years on, what we know, what we don't know, and what we ought to know
WM Zelek, RA Harrison - Immunobiology, 2023 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus was identified in
China in 2019 as the causative agent of COVID-19, and quickly spread throughout the …
China in 2019 as the causative agent of COVID-19, and quickly spread throughout the …